Study of a National Cohort of Adult Patients With Phenylketonuria
NCT ID: NCT01619722
Last Updated: 2021-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
220 participants
OBSERVATIONAL
2012-03-15
2020-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)
NCT06629987
Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288
Observational Study of Endothelial Dysfunction in Phenylketonuria
NCT02176603
Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU)
NCT03777826
Simple Breath Test to Examine Phenylalanine Metabolism
NCT02009904
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Describe the evolution of the disease in adulthood and neurological complications associated neuropsychological detect, investigate the prognostic factors for complications
* Describe the metabolic balance of patients
* Collect data on nutritional status,
* Detect osteoporosis
* Studying social integration and quality of life of adult patients with PKU
* Collect biological samples for further study (markers of bone turnover)
Design:
Cohort :
Duration of the inclusion period: 2 years Duration of subject participation: 5 years Total duration of the study: 7 years
JUDGING CRITERIA:
* Complications associated with PKU in adult
* Evolution of neuropsychometric scores
* Bone mineral density by densitometry
* Measuring the quality of life of patients
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Phenylketonuria (PKU) or moderate persistent Hyperphenylalaninemia (HMP) diagnosed by neonatal screening
* Reading and signing an informed consent
* Membership of a social security system
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François MAILLOT, Pr
Role: STUDY_DIRECTOR
CHRU TOURS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU-Hôpital Bretonneau - Service de Médecine Interne-Nutrition
Tours, Centre-Val de Loire, France
CHU-ANGERS -Médecine Interne
Angers, , France
CHU_Service de Médecine Interne Nutrition A2-Hôpital du Haut Levèque
Bordeaux, , France
CHU du Morvan-Département de Pédiatrie et génétique médicale,
Brest, , France
Hôpital Femme-Mère-Enfant-Centre de Référence des Maladies Héréditaires du Métabolisme de Lyon
Bron, , France
CHU de Dijon--Hôpital des Enfants-Centre de Génétique
Dijon, , France
CHU de Grenoble-Hôpital MICHALLON-Unité de Neurologie Générale
Grenoble, , France
CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie
Lille, , France
APHM-Hôpital de la Conception -Médecine Interne
Marseille, , France
CHU-Service de Réanimation Pédiatrique / Néonatalogie, Consultation spécialisée en Maladies Héréditaires du Métabolisme
Nantes, , France
Hôpital Necker Enfants Malades, APHP-Maladies Métaboliques -Service de Pédiatrie
Paris, , France
CHU-RENNES-Hôpital Sud-Service de Génétique-Clinique
Rennes, , France
CHU de Rouen-Service de Pédiatrie
Rouen, , France
CHU de St Etienne-Hôpital Nord-Service de Pédiatrie
Saint-Etienne, , France
CHU-Toulouse-Hôpital PURPAN-Service de Médecine Interne
Toulouse, , France
University Hospital of NANCY
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRN10/FM-ECOPHEN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.